Skip to main content
Michael Rickels, MD, Endocrinology, Philadelphia, PA, Hospital of the University of Pennsylvania

MichaelRickelsMDMS

Endocrinology • Philadelphia, PA

Diabetes

Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases, University of Pennsylvania Perelman School of Medicine

Join to view full profile

Dr. Rickels is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rickels' full profile

Already have an account?

  • Office

    12-134 Smilow Center for Translational Research
    3400 Civic Center Boulevard
    Philadelphia, PA 19104
    Phone+1 215-746-0025
    Fax+1 215-898-5408
  • Is this information wrong?

Education & Training

  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of Pennsylvania MS, Translational Research, 2002 - 2007
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2005
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2001
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1999

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • PA State Medical License
    PA State Medical License 2000 - 2024
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Philip E. Cryer Lectureship Washington University in St. Louis, MO, 2022
  • D. Walter Cohen, D.D.S. Lectureship in Diabetes Drexel University College of Medicine, Philadelphia, PA, 2017
  • Best of JCEM 2016 The Endocrine Society, 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Islet Transplants in Type 1 Diabetes Durable up to 8 Years
    Islet Transplants in Type 1 Diabetes Durable up to 8 YearsOctober 19th, 2022
  • New Islet Transplant Method Leads to Insulin Independence
    New Islet Transplant Method Leads to Insulin IndependenceOctober 17th, 2022
  • Hormone Infusion Improves Pancreatic Insulin Production in Cystic Fibrosis Patients with or at Risk for Diabetes, Penn Study Finds
    Hormone Infusion Improves Pancreatic Insulin Production in Cystic Fibrosis Patients with or at Risk for Diabetes, Penn Study FindsJuly 21st, 2022
  • Join now to see all

Grant Support

  • Restoring Awareness of Hypoglycemia in Type 1 DiabetesNIH/NIDDK2022–2027
  • Radioimmunoassay and Biomarkers Core/Diabetes Research CenterNIH/NIDDK2015–2027
  • Evaluation of the Entero-Insular (Incretin) Axis in Cystic FibrosisNIH/NIDDK2012–2025
  • A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of 400 mg Twice a Day Oral Ladarixin in Patients with New-Onset Type 1 DiabetesDompé Farmaceutici S.p.A.2021–2024
  • A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D)NIH/NIDDK2019–2024
  • Type 1 Diabetes and Exercise Initiative (TI-DEXI)Helmsley Charitable Trust2017–2024
  • Glucose Counterregulation in Long Standing Type 1 DiabetesNIH/NIDDK2011–2023
  • Supporting Individuals in Need with T1D Impacted by the COVID-19 PandemicHelmsley Charitable Trust2020–2021
  • Glucose-Dependent Insulinotropic Polypeptide and CFTR Loss-of-FunctionCystic Fibrosis Foundation2019–2021
  • Fixed Rate Continuous Subcutaneous Glucagon Infusion (CSGI) vs Placebo in Type 1 Diabetes Mellitus Patients With Recurrent Severe HypoglycemiaXeris Pharmaceuticals2018–2020
  • Type 1 Diabetes Exchange Clinic NetworkHelmsley Charitable Trust2011–2020
  • Integrated and Long-Term Analysis of Islet Product and Recipient Outcomes in the CIT Consortium TrialsJuvenile Diabetes Research Foundation International2019
  • B-Lymphocyte Immunotherapy in Islet TransplantationNIH/NIDDK2004–2017
  • Insulin and Incretin Secretion in Cystic FibrosisCystic Fibrosis Foundation2012–2015
  • Atypical Antipsychotics: Effects on Hepatic Glucose and Lipid Metabolism in HumansNIH/NIDDK2009–2014
  • Center of Excellence for Regenerative MedicinePA Department of Health2008–2012
  • Metabolic Consequences of Islet TransplantationJuvenile Diabetes Research Foundation International2002–2008
  • Beta-Cell Function and Glucagon-Like Peptide-1 in Pancreas and Kidney TransplantationNIH/NIDDK2005–2007
  • University of Pennsylvania School of Medicine Training Grant in Patient-Oriented ResearchNIH/NCRR2003–2006
  • University of Pennsylvania School of Medicine Training Grant in Diabetes, Endocrine and Metabolic DiseasesNIH/NIDDK2002–2003

Committees

  • Member, Steering Committee, Impaired Awareness of Hypoglycemia Consortium, NIDDK 2022 - Present
  • Member, Steering Committee, A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus, Vertex Pharmaceuticals 2021 - Present
  • Co-Chair (2017 - Present), Type 1 Diabetes EXercise Initiative (T1-DEXI), Jaeb Center for Health Research 2016 - Present
  • Member, Advisory Committee, NIDDK Medical Student Research Program 2009 - Present
  • Chair (2010 - Present), Publications and Presentations Committee, Collaborative Islet Transplant Registry, NIDDK 2009 - Present
  • Member, Research Advisory Committee, Type 1 Diabetes Outcomes Program, JDRF International 2015 - 2017
  • Member, Clinical and Integrative Diabetes and Obesity Study Section, NIH 2014 - 2018
  • Chair (2018 - 2019), Data & Safety Monitoring Board, Restoring Insulin Secretion (RISE) Consortium, NIDDK 2012 - 2019
  • Member, SBIR to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Toward an Artificial Pancreas SEP, NIDDK 2012 - 2014
  • Vice-Chair (2015 - 2019), Type 1 Diabetes (T1D) Exchange Clinic Network and Registry, Jaeb Center for Health Research 2011 - 2020
  • Member, Clinical Investigations Study Section, JDRF International 2006 - 2008
  • Chair, Metabolic Study Subcommittee, Clinical Islet Transplantation Consortium, NIH 2004 - 2018

Professional Memberships

  • American Association of Clinical Endocrinologists - AACE
    Member, 2001 - Present
  • American Diabetes Association - ADA
    Scientific Sessions Planning Committee, 2012 - 2014, 2020 - 2022; Associate Editor, Diabetes Care, 2022 - Present
  • Endocrine Society
    Editorial Board, Journal of Clinical Endocrinology & Metabolism, 2009 - 2013; Associate Editor, Endocrine Reviews, 2015 - 2018
  • International Pancreas and Islet Transplant Association
    Elected Councilor, 2015 - 2021; Elected Treasurer, 2023 - Present
  • International Hypoglycemia Study Group
    Member, 2022 - Present

Hospital Affiliations

Dr. Michael Rickels, Dr. Michael Rickels, MD, Dr. M Rickels